Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Genetic polymorphism in CX3CR1 and risk of HIV disease.

McDermott DH, Colla JS, Kleeberger CA, Plankey M, Rosenberg PS, Smith ED, Zimmerman PA, Combadière C, Leitman SF, Kaslow RA, Goedert JJ, Berger EA, O'Brien TR, Murphy PM.

Science. 2000 Dec 15;290(5499):2031. No abstract available.

2.

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.

Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, Autran B, Delfraissy JF, McDermott DH, Murphy PM, Debré P, Théodorou I, Combadière C.

Science. 2000 Mar 24;287(5461):2274-7.

3.

AIDS research. Receptor mutations help slow disease progression.

Cohen J.

Science. 1996 Sep 27;273(5283):1797-8. No abstract available.

PMID:
8815542
4.

Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ.

Science. 1996 Sep 27;273(5283):1856-62. Erratum in: Science 1996 Nov 15;274(5290):1069.

PMID:
8791590
5.

Validation of genetic case-control studies in AIDS and application to the CX3CR1 polymorphism.

Hendel H, Winkler C, An P, Roemer-Binns E, Nelson G, Haumont P, O'Brien S, Khalilli K, Zagury D, Rappaport J, Zagury JF.

J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):507-11.

PMID:
11391174
6.

Host factors and the pathogenesis of HIV-induced disease.

Fauci AS.

Nature. 1996 Dec 12;384(6609):529-34. Review.

PMID:
8955267
7.

A new CX3 CR1 genotype with implications for HIV disease progression.

Roman F, Deroo S, Franck N, Burgy C, Servais J, Schmit JC.

AIDS. 2001 Mar 30;15(5):659-60. No abstract available.

PMID:
11317010
8.

HIV-1 infection in an individual homozygous for the CCR5 deletion allele.

Biti R, Ffrench R, Young J, Bennetts B, Stewart G, Liang T.

Nat Med. 1997 Mar;3(3):252-3. No abstract available.

PMID:
9055842
9.

Contribution of cohort studies in understanding HIV pathogenesis: introduction of the GRIV cohort and preliminary results.

Hendel H, Cho YY, Gauthier N, Rappaport J, Schächter F, Zagury JF.

Biomed Pharmacother. 1996;50(10):480-7. Review.

PMID:
9091061
10.

Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study.

Modi WS, Scott K, Goedert JJ, Vlahov D, Buchbinder S, Detels R, Donfield S, O'brien SJ, Winkler C.

Genes Immun. 2005 Dec;6(8):691-8.

PMID:
16177829
11.

MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment.

Bleiber G, May M, Suarez C, Martinez R, Marzolini C, Egger M, Telenti A; Swiss HIV Cohort Study..

J Infect Dis. 2004 Feb 15;189(4):583-6. Epub 2004 Jan 29.

PMID:
14767809
12.

Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load.

Singh KK, Hughes MD, Chen J, Spector SA.

J Infect Dis. 2005 Jun 1;191(11):1971-80. Epub 2005 Apr 28.

PMID:
15871132
13.

Deleterious genetic influence of CX3CR1 genotypes on HIV-1 disease progression.

Faure S, Meyer L, Genin E, Pellet P, Debré P, Théodorou I, Combadière C; SEROCO Study Group..

J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):335-7.

PMID:
12626895
14.

Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands.

Arenzana-Seisdedos F, Parmentier M.

Semin Immunol. 2006 Dec;18(6):387-403. Epub 2006 Sep 15. Review.

PMID:
16978874
15.

Ethics of AIDS study.

Gomperts ED, Donfield SM.

Science. 1996 Dec 6;274(5293):1596. No abstract available.

PMID:
8984621
16.

[Mechanism of HIV infection].

[No authors listed]

Praxis (Bern 1994). 1997 Apr 23;86(17):692, 699. German. No abstract available.

PMID:
9221475
17.

[Distribution of HIV-1 coreceptor CX3CR1 allelic polymorphisms in general population, HIV-1 high-risk group and HIV-1 carriers of Chinese indigenous Han and Uygur people].

Liu MX, Wang FS, Hong WG, Wang CQ, Wang B, Jin L, Hou J, Lei ZY.

Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Jul;24(7):595-8. Chinese.

PMID:
12975017
18.

Polymorphisms in the interleukin-4 receptor alpha chain gene influence susceptibility to HIV-1 infection and its progression to AIDS.

Soriano A, Lozano F, Oliva H, García F, Nomdedéu M, De Lazzari E, Rodríguez C, Barrasa A, Lorenzo JI, Del Romero J, Plana M, Miró JM, Gatell JM, Vives J, Gallart T.

Immunogenetics. 2005 Oct;57(9):644-54. Epub 2005 Oct 18.

PMID:
16189667
19.

HIV CCR5 resistance incomplete.

Smith O.

Nat Med. 1997 Apr;3(4):372-3. No abstract available.

PMID:
9095162
20.

CCR5-delta 32 gene deletion in HIV-1 infected patients.

Wang B, Palasanthiran P, Zeigler J, Cunningham A, Saksena NK.

Lancet. 1997 Sep 6;350(9079):742. No abstract available.

PMID:
9291932

Supplemental Content

Support Center